Stay updated on INTRUST: Urelumab/Nivolumab Combo Clinical Trial
Sign up to get notified when there's something new on the INTRUST: Urelumab/Nivolumab Combo Clinical Trial page.

Latest updates to the INTRUST: Urelumab/Nivolumab Combo Clinical Trial page
- Check2 days agoChange DetectedTwo new citations were added and two existing citations were removed in the Publications section, resulting in a net-neutral update to the study's references. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedDifference0.2%

- Check23 days agoNo Change Detected
- Check45 days agoChange DetectedThe page revision history now shows a new revision entry v3.3.2 and removes the previous v3.2.0 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedRemoved a general site operating-status notice; the study details content remains the same.SummaryDifference0.3%

- Check66 days agoChange DetectedBoth screenshots depict the same Study Details page for NCT03792724 with only minor UI/layout refinements and no changes to the study design, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check95 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference1.0%

Stay in the know with updates to INTRUST: Urelumab/Nivolumab Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INTRUST: Urelumab/Nivolumab Combo Clinical Trial page.